Altoida | Travis Bond, CEO
Altoida is using technology to predict the onset of neurlogical diseases, such as Alzheimer's disease, before symptoms occur.
Roundtable Keynote: A View from All Sides of the Medtech Innovation Table
A lively discussion to explore lessons learned and opportunities ahead.
Lucid Diagnostics | Lishan Aklog, Chairman
Lucid is developing solutions to help clinicians diagnose and manage the progression of esophageal disease.
Manny Villafaña and Chris Velis Fireside Chat
At LSI USA '22 Emerging Medtech Summit, Life Science Intelligence presented Industry Legend, Manny Villafaña, with the LSI Lifetime Achievement Award in Medical Devices.
Dymicron | Ted Bird, Chief Strategy Officer
Dymicron is an innovation-driven medical technology company that is advancing a new generation of musculoskeletal devices made from Polycrystalline Diamond (PCD), one of the strongest substances known to man, and a material for which Dymicron has exclusive patented use in all human interbody applications.
New Medtech Incubator Models & Early Stage Investing
This panel will explore how a new model of incubators and early-stage corporate investors are driving innovation.
Vicarious Surgical | Adam Sachs, CEO
Transforming surgery through robotics and virtual reality. The Vicarious Surgical robot will offer surgeons a 360 degree view and reach within the patient and surgical field.
Web3, NFTs, and Decentralized Science: The Most Important Topic That You Don't Understand (But Should)
How will Web3, NFTs, and Decentralized Science Impact the future of healthcare?
TibaRay | Jeff Amacker, CEO
TibaRay is developing a next-generation radiation therapy technology, called PHASER, to deliver radiation treatment with unprecedented accuracy and exquisite shaping by ultrafast imaging.
After the Capital Raise: Accelerating into Growth Stage
A lively discussion with CEOs that have successfully raised multiple rounds of capital, and now are accelerating into the next stages of growth.
Nanochon | Ben Holmes, CEO
Nanochon is applying novel materials to replicate bone and cartilage, and high-end 3D printing to create an implant which can permanently repair debilitating joint injuries.
Medtech Investing: What VCs Want Right Now
How have recent market dynamics changed the strategies of active medtech VCs? What kind of deals are they looking and what is catching their interest at LSI USA '22?
OYE Therapeutics | Brett Dines, CEO
OYE (Open Your Eyes) Therapeutic's intervention is set to remove over $5.5B in annual avoidable costs from US hospitals and surgery centers by solving the defined problem of delayed operating room turnover due to extended emergence time from anesthesia.
Aqua Medical | Lloyd Mencinger, President & CEO
Treating gastrointestinal disease with disruptive, vapor-based endoscopic ablation therapy.
Medtech Venture Investing
Let's dig deep and find out what these VCs are looking for and find out where they are focusing their next round of investments.
Day Zero Diagnostics | Jong Lee, CEO & Co-Founder
Day Zero Diagnostics uses whole genome sequencing and machine learning to modernize infectious disease diagnosis and treatment.
Sonic Incytes | Barry Allen, CEO
Velacur is a portable, handheld ultrasound that integrates machine learning to enhance image guidance, resulting in a confident assessment of liver health in all body types.
Same Goal, Different Paths: CEO Spotlight on Raising Capital
This panel will explore different methods to raise capital and explore why these successful CEOs chose their path. We'll discuss the challenges CEOs in our space experience, and address how those challenges can be overcome.
AtriAN Medical | Ken Coffey, CEO
AtriAN Medical is developing an innovative solution for the treatment of AF that utilizes micro-Pulsed Electric Field (mPEF)
Spark Biomedical | Daniel Powell, CEO
Spark Biomedical's FDA-cleared Transcutaneous Auricular Neurostimulation (tAN™) is a non-invasive wearable treatment technology for opioid withdrawal relief.
CoLabs Medical | Clay Nolan, CEO
CoLabs is developing The Ventor, an emergency airway and ventilation system to manage the patients airway during cardiac arrest.
AiM Medical Robotics | Bob Cathcart, President & CEO
AiM Medical Robotics is developing a portable MRI compatible surgical robot for use in the OP and MRI suite. The system is being designed for the treatment of functional brain disorders (e.g. epilepsy, Parkinson's disease).
Wearable Artificial Organs | Victor Gura, CEO
Wearable Artificial Organs is developing truly portable solutions for use in patients with End Stage Renal Disease (ESRD).
Atlantic Therapeutics | Susan Trent, CEO
Wearable technology designed to treat the root cause of female incontinence. The Innovo device engages the pelvic floor muscles via 30 minute sessions that have been clinically proven to reduce and eliminate leaks due to stress urinary incontinence.
Pulse Infoframe | Femida Gwadry-Sridhar, Founder & CEO
Pulse Infoframe has developed a robust platform for accelerating evidence generation and collaborative research through quality real-world data (“RWD”) at scale.
ATRO Medical | Jan Hunik, CEO
ATRO Medical is developing Trammpolin, a prosthetic meniscus made of anatomically shaped polymer for the replacement of damaged menisci.
Entvantage Diagnostics | Joe Skraba, President & CEO
Entvantage Dx is an in-vitro diagnostic company dedicated to reducing antibiotics for ENT illnesses.